Rezvilutamide: yet another androgen receptor pathway inhibitor for metastatic hormone-sensitive prostate cancer?
@article{CCO112516,
author = {Jeanny B. Aragon-Ching},
title = {Rezvilutamide: yet another androgen receptor pathway inhibitor for metastatic hormone-sensitive prostate cancer?},
journal = {Chinese Clinical Oncology},
volume = {12},
number = {2},
year = {2023},
keywords = {},
abstract = {},
issn = {2304-3873}, url = {https://cco.amegroups.org/article/view/112516}
}